Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Detail)

v3.19.3.a.u2
Accrued Expenses (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 5,395 $ 10,119
Employee compensation and benefits 4,174 2,985
Professional fees 694 618
Facilities and other 383 171
Total accrued expenses $ 10,646 $ 13,893